Effect of ondansetron on convulsions and its interactions with phenytoin

Pharmacologyonline

Volumn 3, Issue , 2009, Pages 463-469

  Puthuran, G J ^a   Patil, P A ^b   Majagi, Suneel I ^b  

^a K L E S S COLLEGE OF PHARMACY   (India)

^b JAWAHARLAL NEHRU MEDICAL COLLEGE   (India)

Author keywords

Convulsions; Diazepam; Interaction; Ondansetron; Phenytoin

Indexed keywords

CAMPOSE; DIAZEPAM; DILANDIN; EMSET; ONDANSETRON; PHENYLENETETRAZOL; PHENYTOIN; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DISEASE DURATION; DRUG EFFECT; ELECTRIC SHOCK; MALE; NONHUMAN; RAT; SEIZURE; SEIZURE SUSCEPTIBILITY;

EID: 75649136192     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Waxman Stephen G. Epilepsy. In: Correlative Neuroanatomy, Appleton & Lange, A Simon & Schuster Company, Stamford.1996:280-282.
2. Vogel H Gerhard. et al., Antiepileptic activity in drug discovery and evaluation. Springerverlay, New York.1997:246.
3. Mc Namara O. James. Drugs effective in the therapy of the epilepsies. In: Pharmacological basis of therapeutics. Hardman G.J et al. Mac-Graw-Hill Co., New York, 1996: 463-467.
4. Gupta YK, Malhotra J.Antiepileptic drug therapy in the twenty first century.Indian J Physiol Pharmacol. 2000 Jan;44(1):8-23.
5. William BC, Lipid derived autocoids:Eicosanoids and platelet activation factor. In: Pharmacological basis of therapeutics. Hardman GJ et al., Mac-Graw-Hill Companies, New York, 1996:601-616.
6. Wali RS, Patil PA. Aspirin and anticonvulsant interaction.Indian J Physiol Pharmacol.1995:39(1):77-79.
7. Schachter SC.Hormonal considerations in women with seizures.Arch Neurol. 1988: Nov;45(11):1267-70.
8. Kankanwadi SK,Patil PA.Female gonadal sex steroids potentiate the anticonvulsant activity of phenytoin sodium.Indian Journal of Experimental Biology.1998:vol 36, 713-715.
9. Yan QS, Jobe PC, Dailey JW.Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol. 1994 Jan 24;252(1):105-112.
10. Bush SE, Mayer ES. 5-Hydroxytryptamine receptor agonists and antagonists. In: Pharmacological basis of therapeutics. Hardaman GJ et al, McGraw- Hill Compnies, New York,1996:249-263.
11. Ye JH, Mui WC, Ren J et al.,Ondansetron exhibits the properties of a local anesthetic. Anesth Analg. 1997 Nov;85(5):1116-21.
12. Plaznik A, Stefański R, Jessa M, Nazar M, Bidziński A.Central serotonergic system and mechanism of anxiolytic action. Acta Physiol Hung. 1996;84(4):449-51.
13. Plaznik AJ et.al. Ondansetron exhibits the properties of local anesthetic. Anesth-Analg.1997;85 (5):1116-1121.
14. Swain TR, Mohanty M. Antiepileptic action of ondansetron. Indian J Pharmacol 1999;31:157-58.
15. Commission on classification and terminology of the international league against epilepsy. Proposal for revised clinical and electrocencephalographic classification of epileptic seizures. Epilepsia.1981;22:489-501.
16. Toman JEP, Swinyard EA, Goodman LS.Properties of maximal seizures and their alteration by anticonvulsant drugs and other agents. J Neumophysiol.1946.9:231-239.
17. Swinyard EA, Brown WC, Goodman LS. Comparative assays of antiepileptic drugs in mice and rats. J.Pharmacol.Exp.Ther.,106:319-330.
18. Louis WJ, Papanicolaou J, Summers RJ, Vajda FJ. Role of central Beta-adrenoreceptors in the control of PTZ induced convulsion in rats. Br.J. Pharm.,75:441-446.
19. Balakrishnan S, Bhargava VK, Pandhi P. Anticonvulsant profile of ondansetron in rats. Epilepsy Behav. 2000 Feb; 1(1):22-26.
20. Blandina P, Goldfarb J, Walcott J, Green JP. Serotonergic modulation of the release of endogenous norepinephrine from rat hypothalamic slices. J Pharmacol Exp Ther. 1991. Jan;256(1):341-7.
21. Browning RA, Wade DR, Marcinczyk M, Long GL, Jobe PC .Regional brain abnormalities in norepinephrine uptake and dopamine beta- hydroxylase activity in the genetically epilepsy-prone rat. J Pharmacol Exp Ther. 1989; 249: 229-235.
22. Azzaro AJ, Wenger GR, Craig CR, Stitzel RE. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice. J Pharmacol Exp Ther. 1972 Mar;180(3):558-568.
23. Waterhouse BD, Moises HC, Yeh HH, Woodward DJ.Norepinephrine enhancement of inhibitory synaptic mechanisms in cerebellum and cerebral cortex: mediation by beta adrenergic receptors. J Pharmacol Exp Ther. 1982 May;221(2):495-506.